UN

Uni-Bio Science Group Ltd

Develops biopharma therapies for endocrinology, ophthalmology, and dermatology needs.

690 | HKEX

Overview

Corporate Details

ISIN(s):
KYG9198H1406
LEI:
Country:
Hong Kong
Address:
N/A
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Uni-Bio Science Group Ltd. is an integrated biopharmaceutical company focused on the research, development, manufacturing, and commercialization of innovative therapies. The company's core research areas include endocrinology (such as diabetes and osteoporosis), ophthalmology (addressing conditions like dry eye and corneal injury), and dermatology, including medical aesthetics and wound healing. Uni-Bio Science operates across four integrated technology platforms: new drug research, clinical development, production and quality control, and commercial sales. Its pipeline features a differentiated portfolio of biological and chemical drugs, including proprietary treatments like Bogutai® and Uni-GLP-1, as well as cosmetic peptides and stem cell exosomes, aiming to address significant unmet medical needs and improve patient quality of life.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Uni-Bio Science Group Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Uni-Bio Science Group Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Uni-Bio Science Group Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Phio Pharmaceuticals Corp. Logo
Developing RNAi-based immuno-oncology therapeutics for melanoma and other skin cancers.
United States of America
PHIO
Phoenix Asia Holdings Ltd Logo
A subcontractor for substructure projects and a large-scale manufacturer of fine chemicals & APIs.
United States of America
PHOE
Photocure ASA Logo
Develops photodynamic pharmaceuticals and devices to enhance bladder cancer detection for urologists.
Norway
PHO
Pierrel Logo
Global pharma company specializing in dental anesthetics and contract manufacturing services.
Italy
PRL
PLIANT THERAPEUTICS, INC. Logo
Developing novel integrin-based therapies for fibrosis and related diseases.
United States of America
PLRX
Develops DNA vaccines and therapeutics for companion animals and livestock.
South Korea
222670
Pluri Inc. Logo
Develops placenta-based cell therapeutics using a proprietary 3D cell-expansion platform.
Israel
PLUR
PLUS THERAPEUTICS, INC. Logo
Developing targeted radiotherapeutics for hard-to-treat cancers like glioblastoma and solid tumors.
United States of America
PSTV
PMV Pharmaceuticals, Inc. Logo
Developing small molecule therapies targeting p53 mutations to treat cancer.
United States of America
PMVP
A global supplier of generic APIs using AI to accelerate drug development.
South Korea
041910

Talk to a Data Expert

Have a question? We'll get back to you promptly.